Long before "hormone therapy" was a clinical term, it was a cosmetics counter pitch. Starting in the late 1920s, hormone creams promised to restore youth using animal-gland extracts and, later, synthesized estrogens. Most of it was marketing that outran the evidence — and the history shows exactly how to spot the difference between a claim and a citation.
Dr. Kurt Richter GmbH, a Berlin biological-materials supplier, helped seed the ingredient trade. A year later, Amor Skin — widely considered the first hormone beauty product sold in America — used turtle and lizard gland secretions, packaged in ornate lamps priced up to $25.00.
OriginHelena Rubinstein's Hormone Twin Youthifiers promised "actual youth-hormones" at $10.00 a jar. Leichner sold hormone tablets instead, doubting skin could absorb them. In 1932, Hormez Laboratory launched what the trade press called the first true oestrogenic cream sold in America.
Early marketingFrench salons applied hormone treatments as facial masks, and a standardized recipe — ovarian hormones plus mammary extract — was published for the trade. In Holland, Organon began manufacturing estrone at industrial scale: hormone cosmetics were now a supply chain, not a novelty.
IndustrializationEndocreme became the first oestrogenic cream to sell widely. Then chemists synthesized DES in 1938 — cheaper and three times more potent than natural estrogen, and quickly adopted industry-wide. That same year, the Food, Drug and Cosmetic Act put hormone creams under federal oversight for the first time.
Turning pointHelena Rubinstein released Gourielli Estrolar Cream with "Glandiol," a blend of estrone and estradiol — her first product to name estrogens outright instead of vague "youth-hormones."
Naming the ingredientThe FDA told chemist Maison deNavarre it doubted hormone creams' claims but lacked evidence of harm. It set 10,000 IU of estrogen per ounce as the ceiling for over-the-counter products — the category's first real guardrail — the same year researchers offered a scientific rationale for the anti-wrinkle claims.
First regulatory limitThe FDA seized 223 bottles of Hormonex Beauty Serum at fifteen times the legal limit; the brand reformulated and won approval. A year later, it destroyed jars of Bette Knowlton Special Formula Cream for the same reason — enough estrogen to risk entering the bloodstream.
FDA actionMax Factor's Cup of Youth signaled real money in the category. Helena Rubinstein went further with Ultra Feminine Face Cream, combining progesterone and estrogen and advertising it like a drug, not a beauty product.
Peak commercializationThe contraceptive pill reshaped public and scientific understanding of how hormones act systemically, not just on skin. Regulators in the U.S. and abroad began to take a harder look at over-the-counter hormone cosmetics.
Scientific shiftRevlon's Eterna 27 used a hormone precursor called Progenitin — but marketed it as having "no hormone activity," a sharp break from Rubinstein's medical-sounding claims and an early signal of where regulation was heading.
The pivotThe European Economic Community banned hormones from over-the-counter products outright. The U.S. passed no equivalent law, but rising compliance costs pushed most brands to quietly abandon hormone creams for less-regulated ingredients like phytosterols.
Regulatory divergenceOf the many hormone creams that once lined drugstore shelves, only Eterna 27 remained by century's end — the last trace of an industry that sold youth for thirty years with little oversight of what was actually in the jar.
LegacyThe hormone cream era was never really about hormones. It was about the gap between what a product claims and what a woman reading the label can verify. That gap hasn't closed — it's just moved. The conversation around menopause and hormone therapy still runs on the same fault line: marketing language dressed as medicine.
Find the menopause evidence and information you can trust.
Explore Selfority